<?xml version="1.0" encoding="UTF-8"?>
<p>The SBRA and the REDLARA published a joint note on March 17 2020, firstly suggesting that infertility treatments should continue as planned to avoid reducing prospects of success in infertile women but that the advice of international societies to postpone embryo transfers should be followed (
 <xref rid="r31" ref-type="bibr">SBRA &amp; REDLARA, 2020</xref>). Then, an update launched on March 20 2020 recommended that ongoing cycles should be finalized and new procedures should not be initiated. Embryo transfer must be assessed individually with strict controls on the patients and teams involved and the exceptions lies on oncological and others situations in which the postponement may cause loss to the patient, since the decision need to be shared (
 <xref rid="r31" ref-type="bibr">SBRA &amp; REDLARA, 2020</xref>).
</p>
